In: Accounting
Selk Steel Co., which
began operations on January 4, 2017, had the following subsequent
transactions and events in its long-term investments.
2017
Jan. | 5 | Selk purchased 60,000 shares (20% of total) of Kildaire's common stock for $1,560,000. | ||
Oct. | 23 | Kildaire declared and paid a cash dividend of $3.20 per share. | ||
Dec. | 31 | Kildaire’s net income for 2017 is $1,164,000, and the fair value of its stock at December 31 is $30.00 per share. |
2018
Oct. | 15 | Kildaire declared and paid a cash dividend of $2.60 per share. | ||
Dec. | 31 | Kildaire’s net income for 2018 is $1,476,000, and the fair value of its stock at December 31 is $32.00 per share. |
2019
Jan. | 2 | Selk sold all of its investment in Kildaire for $1,894,000 cash. |
Problem 15-4A Part 2
Part 2
Assume that although Selk owns 20% of Kildaire’s outstanding stock,
circumstances indicate that it does not have a significant
influence over the investee and that it is classified as an
available-for-sale security investment.
Required:
1. Prepare journal entries to record the preceding
transactions and events for Selk. Also prepare an entry dated
January 2, 2019, to remove any balance related to the fair value
adjustment. (If no entry is required for a
transaction/event, select "No journal entry required" in the first
account field.)
Part 2 | |||
Date | General Journal | Debit | Credit |
01-05-17 | Long term investments-AFS (kildaire) | 1560000 | |
Cash | 1560000 | ||
23-10-17 | Cash | 192000 | |
Dividend Revenue | 192000 | ||
(60000*$3.20) | |||
31-12-17 | Fair value adjustment-AFS | 240000 | |
Unrealised gain-equity | 240000 | ||
($30-$26)*60000 shares | |||
15-10-18 | Cash | 156000 | |
Dividend Revenue | 156000 | ||
(60000*$2.60) | |||
31-12-18 | Fair value adjustment-AFS | 120000 | |
Unrealised gain-equity | 120000 | ||
($32-$30)*60000 | |||
02-01-19 | Cash | 1894000 | |
Gain on sale of investment | 334000 | ||
Long term investments-AFS (kildaire) | 1560000 | ||
02-01-19 | Unrealised gain-equity | 360000 | |
Fair value adjustment-AFS | 360000 |